<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> has been promoted as a method for identifying high-risk individuals for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We therefore sought to compare this syndrome, as defined by the National Cholesterol Education Program, to the <z:mp ids='MP_0002055'>Diabetes</z:mp> Predicting Model and the Framingham Risk Score as predictors of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: A population-based sample of 1,709 initially nondiabetic San Antonio Heart Study (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SAHS</z:e>) participants were followed for 7.5 years, 195 of whom developed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Over the same time interval, 156 of 2,570 SAHS participants experienced a cardiovascular event </plain></SENT>
<SENT sid="4" pm="."><plain>A population-based sample of 1,353 initially nondiabetic Mexico City <z:mp ids='MP_0002055'>Diabetes</z:mp> Study (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCDS</z:e>) participants were followed for 6.5 years, 125 of whom developed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Baseline measurements included medical history, age, sex, ethnicity, smoking status, BMI, blood pressure, fasting and 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels, and fasting serum total and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The sensitivities for predicting <z:mp ids='MP_0002055'>diabetes</z:mp> with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> were 66.2 and 62.4% in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SAHS</z:e> and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCDS</z:e>, respectively, and the false-positive rates were 27.8 and 38.7%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The sensitivity and false-positive rates for predicting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SAHS</z:e> were 67.3 and 34.2%, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>At corresponding false-positive rates, the two predicting models had significantly higher sensitivities and, at corresponding sensitivities, significantly lower false-positive rates than the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> for both end points </plain></SENT>
<SENT sid="9" pm="."><plain>Combining the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> with either predicting model did not improve the prediction of either end point </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is inferior to established predicting models for either type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>